0.00Open7.00Pre Close0 Volume2 Open Interest73.00Strike Price0.00Turnover90.59%IV1.55%PremiumDec 13, 2024Expiry Date5.78Intrinsic Value100Multiplier1DDays to Expiry1.22Extrinsic Value100Contract SizeAmericanOptions Type0.9492Delta0.0279Gamma13.58Leverage Ratio-0.0900Theta0.0019Rho12.89Eff Leverage0.0043Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet